Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds 
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal 
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies 
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger 
France Keeps Top Health Alert as Officials Brace for Another Heatwave 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak 
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility? 
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds 
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks 
While there is no definitive cure for cancer just yet, scientists continue to research and experiment with various methods of treatment. Recently it was reported that a new drug may help beat the disease, specifically leukemia.
Express reports that a new drug may help patients suffering from leukemia while sparing them from the toxic side-effects that may come along with the treatment. The drug is referred to as asciminib and a study that was conducted as a trial for this drug found that the patients who took it responded well and that the drug did not cause any harmful side effects. The normal drugs that help treat leukemia usually come with many unpleasant side effects like diarrhea, vomiting, and muscle pain, contributing to the pain the patients are already feeling. The researchers behind the drug say that this serves as a breakthrough as asciminib does not kill the healthy cells nor cause the side effects.
In the study with 150 participants, no one found the drug toxic in any way.
Asciminib slows down the cancer by inhibiting certain cancer-causing enzymes called Kinases, which is part of a type of drugs referred to as tyrosine kinase inhibitors or TKI. South Australian Health and Medical Research Institute Professor Tim Hughes, who also serves as a co-author of the study, believes that if asciminib is successful in its development stages, then this would be a breakthrough in treating leukemia, specifically chronic myeloid leukemia, since the 1990s.
Other breakthroughs with other types of cancer have also been made. Express previously reported that the International Alliance for Cancer Early Detection - made up of scientists from various cancer institutes in the United Kingdom - were able to create a tumor that could help them understand how a cancer is being born and so they can formulate a way to prevent the disease from evolving further.
Using cells from a person with a high risk of developing cancer, scientists hope to create a “living laboratory” to see what kind of conditions will the tumor develop. The scientists will reproduce the tissue with a 3D printer, and conduct further experiments to see what factors will be cancerous.
